NICE guidance on type-2 diabetes

Draft NICE guidelines on type-2 diabetes have backed second-line use of DPP-4 inhibitors and glitazones in some patients.

The recommendations cover DPP-4 inhibitors (sitagliptin and vildagliptin), glitazones (pioglitazone and rosiglitazone) and exenatide, as well as when to start insulin therapy.

Metformin and a sulphonylurea remain preferred first- and second-line agents, but for patients not suitable for this treatment and who are uncontrolled on one of them, a DPP-4 inhibitor or a glitazone is recommended as an add-on therapy.

Exenatide can be added to metformin and a sulphonylurea for obese patients and those unsuitable for insulin therapy.

tom.moberly@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

How our practice is supporting staff wellbeing during the pandemic

How our practice is supporting staff wellbeing during the pandemic

Dr Vasu Siva explains the steps her practice has taken to support staff to look after...

GPs to contact all children on shielding lists this summer

GPs to contact all children on shielding lists this summer

GP practices will be asked to contact thousands of children on shielding lists over...

Fever in adults - red flag symptoms

Fever in adults - red flag symptoms

Pyrexia in adults has a wide range of differential diagnoses. Dr Pipin Singh provides...

GMC to restart fitness to practise cases and PLAB tests within weeks

GMC to restart fitness to practise cases and PLAB tests within weeks

Fitness to practise cases paused during the coronavirus pandemic will restart this...

NHS England confirms plan to add practice managers to £20,000 golden hello scheme

NHS England confirms plan to add practice managers to £20,000 golden hello scheme

NHS England hopes to extend the £20,000 golden hello scheme for first-time partners...

COVID-19 risk assessments could devastate fragile GP workforce in parts of England

COVID-19 risk assessments could devastate fragile GP workforce in parts of England

COVID-19 risk assessments could devastate the threadbare primary care workforce in...